These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. 27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3. Shen Z; Zhu D; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y Environ Toxicol Pharmacol; 2017 Apr; 51():1-8. PubMed ID: 28257824 [TBL] [Abstract][Full Text] [Related]
45. Dynamin function is important for chemokine receptor-induced cell migration. Jacques RO; Mills SC; Cazzonatto Zerwes P; Fagade FO; Green JE; Downham S; Sexton DW; Mueller A Cell Biochem Funct; 2015 Aug; 33(6):407-14. PubMed ID: 26350225 [TBL] [Abstract][Full Text] [Related]
46. gammadeltaT cell-mediated regulation of chemokine producing macrophages during Listeria monocytogenes infection-induced inflammation. Tramonti D; Rhodes K; Martin N; Dalton JE; Andrew E; Carding SR J Pathol; 2008 Oct; 216(2):262-70. PubMed ID: 18767021 [TBL] [Abstract][Full Text] [Related]
47. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. Giri RK; Rajagopal V; Kalra VK J Neurochem; 2004 Dec; 91(5):1199-210. PubMed ID: 15569263 [TBL] [Abstract][Full Text] [Related]
48. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700 [TBL] [Abstract][Full Text] [Related]
49. Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis. Wright KM; Friedland JS J Leukoc Biol; 2004 Jun; 75(6):1086-92. PubMed ID: 14982951 [TBL] [Abstract][Full Text] [Related]
50. Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF. Kaur J; Sanyal SN Mol Carcinog; 2011 Sep; 50(9):707-18. PubMed ID: 21268133 [TBL] [Abstract][Full Text] [Related]
51. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes. Brueckmann M; Hoffmann U; De Rossi L; Weiler HM; Liebe V; Lang S; Kaden JJ; Borggrefe M; Haase KK; Huhle G Cytokine; 2004 May; 26(3):106-13. PubMed ID: 15135804 [TBL] [Abstract][Full Text] [Related]
52. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines. Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597 [TBL] [Abstract][Full Text] [Related]
53. Rubratoxin-B-induced secretion of chemokine ligands of cysteine-cysteine motif chemokine receptor 5 (CCR5) and its dependence on heat shock protein 90 in HL60 cells. Nagashima H Environ Toxicol Pharmacol; 2015 Nov; 40(3):997-1000. PubMed ID: 26595743 [TBL] [Abstract][Full Text] [Related]
54. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Simitsopoulou M; Roilides E; Likartsis C; Ioannidis J; Orfanou A; Paliogianni F; Walsh TJ Antimicrob Agents Chemother; 2007 Mar; 51(3):1048-54. PubMed ID: 17178797 [TBL] [Abstract][Full Text] [Related]
55. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. Stanford MM; Issekutz TB J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247 [TBL] [Abstract][Full Text] [Related]
56. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes. Bala M; Kopp A; Wurm S; Büchler C; Schölmerich J; Schäffler A Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):370-6. PubMed ID: 21104588 [TBL] [Abstract][Full Text] [Related]
57. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes. Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252 [TBL] [Abstract][Full Text] [Related]